Literature DB >> 1787074

Hepatic uptake of [99mTc]galactosyl-neoglycoalbumin is sensitive to receptor quantity.

M Kudo1, D R Vera, W L Trudeau, R C Stadalnik.   

Abstract

[Technetium-99m]galactosyl-neoglycoalbumin (TcNGA) is a synthetic radioligand specific to the receptor, hepatic binding protein (HBP), which resides exclusively at the cell surface of hepatocytes. If the TcNGA time-activity data are to provide valid estimates of receptor biochemistry via pharmacokinetic modeling, the shape of the hepatic uptake curve must change with alterations in receptor concentration or affinity. An index of TcNGA hepatic uptake, T90, was obtained by calculating the time at which the liver time-activity curve reached 90% of its maximum. Receptor quantity was measured by Scatchard binding assay of liver biopsy samples obtained prior to each TcNGA study. The range of T90 was 3.7-16.8 min; HBP quantity ranged from 0.022 to 0.100 mumol. Significant correlation (r) and slope (b) was observed between T90 and HBP quantity (r = 0.82, P = 0.003; tb = 3.98, P = 0.003). We concluded that the hepatic uptake of TcNGA is sensitive to HBP quantity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1787074     DOI: 10.1016/0883-2897(91)90003-4

Source DB:  PubMed          Journal:  Int J Rad Appl Instrum B        ISSN: 0883-2897


  3 in total

1.  Biodistribution and excretion of monosaccharide-albumin conjugates measured with in vivo near-infrared fluorescence imaging.

Authors:  Thomas E McCann; Nobuyuki Kosaka; Makoto Mitsunaga; Peter L Choyke; Jeffrey C Gildersleeve; Hisataka Kobayashi
Journal:  Bioconjug Chem       Date:  2010-10-20       Impact factor: 4.774

2.  Development of ⁶⁸Ga-labelled DTPA galactosyl human serum albumin for liver function imaging.

Authors:  Roland Haubner; David R Vera; Salman Farshchi-Heydari; Anna Helbok; Christine Rangger; Daniel Putzer; Irene J Virgolini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-12       Impact factor: 9.236

Review 3.  Concepts for design and analysis of receptor radiopharmaceuticals: The Receptor-Binding Radiotracers series of meetings provided the foundation.

Authors:  Kenneth A Krohn; David R Vera
Journal:  Nucl Med Biol       Date:  2020-03-12       Impact factor: 2.408

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.